Observational Study of Endoscopic Submucosal Dissection (ESD)

This study is looking at a procedure called Endoscopic Submucosal Dissection (ESD). ESD is a way to remove deep growths or lesions from your gastrointestinal (GI) tract, which includes areas like your esophagus (food pipe). This procedure is done as an outpatient, meaning you don't stay overnight in the hospital. The study aims to see how well ESD works for treating lesions in the GI tract, including those related to Barrett Esophagus. You can join if you are 18 or older and are already scheduled to have an ESD procedure. The study will follow your progress for 12 months to see the results. This is an observational study, meaning you will receive standard medical care, and no experimental treatments are involved. The study is currently unclear about its recruitment status and plans to enroll 1000 participants.

Study design
This is an observational study, meaning researchers will watch and collect information about patients undergoing a standard medical procedure. There is no specified phase for this study, and it plans to enroll 1000 participants.
What's involved
You would be participating if you are already scheduled to undergo Endoscopic Submucosal Dissection (ESD). All patients will receive standard medical care.
Compensation
Not stated in the trial record.
Follow-up
The study will evaluate the utility of ESD for treatment of gastrointestinal lesions at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05468008

Endoscopic Submucosal Dissection (ESD)

Recruiting
Not specifiedAges 18+Observational
AdventHealth
~1,000 participants
Updated 2026-02-02 on ClinicalTrials.gov
What's tested:Endoscopic Submucosal Dissection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Evaluate the utility of ESD for treatment of gastrointestinal lesions
Measured over 12 months
Esophageal Lesion
Barrett Esophagus
Gastrointestinal Lesions
1 sites across 1 states
Florida1
  • Dennis Yang, MD · PRINCIPAL_INVESTIGATOR · AdventHealth Orlando

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Scheduled to undergo ESD

Exclusion

Any contraindication to performing endoscopy
Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
  • Evaluate the utility of ESD for treatment of gastrointestinal lesions12 months

    The primary endpoint of this study will be the prospective evaluation of the utility of ESD for the endoscopic treatment of GI lesions.